Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - MOTT DAVID M

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for MOTT DAVID M
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-06-27
Sale
2019-06-28
7:05 pm
Epizyme Inc. EPZM MOTT DAVID M
Director
52,473 $12.43 $652,134 3,971,018
(Indirect
Direct)
View
2019-06-24
Sale
2019-06-26
5:16 pm
Epizyme Inc. EPZM MOTT DAVID M
Director
104,944 $13.08 $1,372,825 3,971,018
(Indirect
Direct)
View
2019-06-24
Purchase
2019-06-25
4:51 pm
GENOCEA BIOSCIENCES Inc GNCA MOTT DAVID M
10% Owner
2,857,142 $3.5 $9,999,997 7,225,676
(Indirect)
View
2019-05-09
Purchase
2019-05-13
5:14 pm
Trevi Therapeutics Inc. TRVI MOTT DAVID M
10% Owner
2,500,000 $10 $25,000,000 4,438,562
(Indirect)
View
2019-05-07
Purchase
2019-05-09
6:06 pm
Regulus Therapeutics Inc. RGLS MOTT DAVID M
10% Owner
1,136,704 $1.08 $1,227,640 3,703,704
(Indirect)
View
2019-04-08
Purchase
2019-04-08
5:21 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
4,347,827 $1.14 $4,956,523 25,243,864
(Indirect)
View
2019-03-05
Purchase
2019-03-06
4:39 pm
Mersana Therapeutics Inc. MRSN MOTT DAVID M
Director, 10% Owner
3,750,000 $4 $15,000,000 11,890,138
(Indirect)
View
2019-02-14
Purchase
2019-02-19
5:04 pm
GENOCEA BIOSCIENCES Inc GNCA MOTT DAVID M
10% Owner
9,948,269 $0.4713 $4,688,619 34,948,268
(Indirect)
View
2018-12-20
Purchase
2018-12-21
9:18 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
500,000 $1.549 $774,440 20,896,038
(Indirect)
View
2018-12-14
Purchase
2018-12-14
6:22 pm
Ra Pharmaceuticals Inc. RARX NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
10% Owner
645,161 $15.5 $9,999,996 6,135,234
(Direct)
View
2018-12-11
Purchase
2018-12-12
4:43 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
61,200 $1.979 $121,084 20,396,038
(Indirect)
View
2018-12-06
Purchase
2018-12-10
5:22 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
170,400 $1.986 $338,352 20,334,838
(Indirect)
View
2018-11-28
Purchase
2018-11-30
5:13 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
96,400 $1.98 $190,891 20,164,438
(Indirect)
View
2018-11-20
Purchase
2018-11-21
4:42 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
170,000 $1.977 $336,107 20,068,038
(Indirect)
View
2018-11-15
Purchase
2018-11-19
7:44 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
1,200,000 $1.865 $2,237,971 19,898,038
(Indirect)
View
2018-10-22
Purchase
2018-10-24
5:01 pm
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
1,800,000 $5 $9,000,000 6,641,634
(Indirect)
View
2018-10-05
Purchase
2018-10-05
6:36 pm
Epizyme Inc. EPZM MOTT DAVID M
Director
416,667 $9 $3,750,003 6,471,018
(Indirect
Direct)
View
2018-09-07
Purchase
2018-09-10
4:48 pm
Adaptimmune Therapeutics PLC ADAP MOTT DAVID M
Director, 10% Owner
15,000,000 $1.667 $25,000,500 82,978,672
(Indirect)
View
2018-08-21
Purchase
2018-08-22
4:45 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
663,716 $2.26 $1,499,998 18,698,038
(Indirect)
View
2018-07-18
Purchase
2018-07-20
4:44 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
250,600 $1.962 $491,745 18,034,322
(Indirect)
View
2018-06-27
Purchase
2018-06-28
7:20 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
192,425 $2.1 $404,077 17,783,722
(Indirect)
View
2018-05-30
Purchase
2018-05-30
5:14 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
275 $2.15 $591 17,591,296
(Indirect)
View
2018-05-17
Purchase
2018-05-21
5:25 pm
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
236,479 $2.129 $503,423 17,591,022
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-07-02
Option Award
2019-07-03
5:41 pm
2020-07-20
2029-07-02
Adaptimmune Therapeutics PLC ADAP MOTT DAVID M
Director, 10% Owner
350,947 $0.61 350,947
(Direct)
View
2019-06-30
Option Award
2019-07-02
4:28 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
1,868 $12.55 3,971,018
(Direct)
View
2019-06-24
Other
2019-06-26
5:16 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
2,500,000 $0 3,971,018
(Indirect)
View
2019-06-24
Other
2019-06-26
5:16 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
767,500 $0 3,971,018
(Indirect)
View
2019-06-24
Other
2019-06-26
5:16 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
767,500 $0 3,971,018
(Indirect)
View
2019-06-24
Other
2019-06-26
5:16 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
38,646 $0 3,971,018
(Indirect)
View
2019-06-24
Other
2019-06-26
5:16 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
157,417 $0 3,971,018
(Indirect)
View
2019-06-13
Option Award
2019-06-17
5:12 pm
N/A
N/A
ARDELYX Inc ARDX MOTT DAVID M
Director, 10% Owner
32,846 $0 3,082,186
(Direct)
View
2019-06-13
Option Award
2019-06-17
5:12 pm
N/A
2029-06-13
ARDELYX Inc ARDX MOTT DAVID M
Director, 10% Owner
50,000 $2.74 3,082,186
(Direct)
View
2019-06-07
Option Award
2019-06-11
4:49 pm
N/A
2029-06-07
Mersana Therapeutics Inc. MRSN MOTT DAVID M
Director, 10% Owner
25,000 $4.31 25,000
(Direct)
View
2019-03-31
Option Award
2019-06-07
4:44 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
1,891 $12.39 6,471,018
(Direct)
View
2019-03-31
Option Award
2019-06-07
4:44 pm
N/A
2029-05-30
Epizyme Inc. EPZM MOTT DAVID M
Director
17,633 $13.74 6,471,018
(Direct)
View
2019-06-07
Disposition
2019-06-07
4:44 pm
N/A
N/A
Nightstar Therapeutics plc NITE MOTT DAVID M
Director, 10% Owner
6,662,532 $25.5 0
(Indirect)
View
2019-06-07
Disposition
2019-06-07
4:44 pm
N/A
2028-02-27
Nightstar Therapeutics plc NITE MOTT DAVID M
Director, 10% Owner
36,400 $13.23 0
(Direct)
View
2019-06-07
Disposition
2019-06-07
4:44 pm
N/A
2029-01-24
Nightstar Therapeutics plc NITE MOTT DAVID M
Director, 10% Owner
21,000 $11.93 0
(Direct)
View
2019-05-09
Conversion
2019-05-13
5:14 pm
N/A
N/A
Trevi Therapeutics Inc. TRVI MOTT DAVID M
10% Owner
1,938,562 $0 4,438,562
(Indirect)
View
2019-05-09
Conversion
2019-05-13
5:14 pm
N/A
N/A
Trevi Therapeutics Inc. TRVI MOTT DAVID M
10% Owner
17,099,316 $0 4,438,562
(Indirect)
View
2019-05-07
Purchase
2019-05-09
6:06 pm
2019-05-07
2024-05-07
Regulus Therapeutics Inc. RGLS MOTT DAVID M
10% Owner
3,703,704 $0.125 3,703,704
(Indirect)
View
2019-05-07
Purchase
2019-05-09
6:06 pm
2019-05-07
N/A
Regulus Therapeutics Inc. RGLS MOTT DAVID M
10% Owner
256,700 $10.8 3,703,704
(Indirect)
View
2019-04-08
Purchase
2019-04-08
5:21 pm
2019-04-08
2021-04-08
AVEO PHARMACEUTICALS INC AVEO MOTT DAVID M
10% Owner
4,347,827 $0.01 25,243,864
(Indirect)
View
2019-02-14
Purchase
2019-02-19
5:04 pm
2019-02-14
2024-02-14
GENOCEA BIOSCIENCES Inc GNCA MOTT DAVID M
10% Owner
2,487,067 $0.125 34,948,268
(Indirect)
View
2019-01-25
Option Award
2019-01-29
9:07 pm
N/A
2029-01-24
Nightstar Therapeutics plc NITE MOTT DAVID M
Director, 10% Owner
21,000 $13.57 21,000
(Direct)
View
2019-01-22
Equity Swap
2019-01-22
10:06 am
N/A
N/A
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
15,362 $75 0
(Direct)
View
2019-01-22
Equity Swap
2019-01-22
10:06 am
N/A
N/A
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
9,681,038 $75 0
(Indirect)
View
2019-01-22
Equity Swap
2019-01-22
10:06 am
N/A
N/A
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
739,517 $75 0
(Indirect)
View
2019-01-22
Equity Swap
2019-01-22
10:06 am
N/A
N/A
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
1,333 $75 0
(Indirect)
View
2019-01-22
Disposition
2019-01-22
10:06 am
N/A
N/A
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
4,052 $0 0
(Direct)
View
2019-01-22
Disposition
2019-01-22
10:06 am
N/A
2023-06-03
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
10,000 $46.22 0
(Direct)
View
2019-01-22
Disposition
2019-01-22
10:06 am
N/A
2024-06-01
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
10,000 $26.36 0
(Direct)
View
2019-01-22
Disposition
2019-01-22
10:06 am
N/A
2025-05-31
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
10,000 $60.77 0
(Direct)
View
2019-01-22
Disposition
2019-01-22
10:06 am
N/A
2026-06-01
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
12,000 $47.27 0
(Direct)
View
2019-01-22
Disposition
2019-01-22
10:06 am
N/A
2027-06-01
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
12,000 $149.2 0
(Direct)
View
2019-01-22
Disposition
2019-01-22
10:06 am
N/A
2028-06-01
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
7,290 $46.89 0
(Direct)
View
2019-01-02
Option Award
2019-01-04
4:34 pm
N/A
2029-01-02
Mersana Therapeutics Inc. MRSN MOTT DAVID M
Director, 10% Owner
25,292 $4.31 25,292
(Direct)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
4,841,634 $0 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
49,030 $0.12 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
49,030 $0.12 6,641,634
(Indirect)
View
2018-10-22
Sale
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
1,177 $5 6,641,634
(Indirect)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
3,279,627 $0 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
181,190 $0.12 6,641,634
(Indirect)
View
2018-10-22
Exercise
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
181,190 $0.12 6,641,634
(Indirect)
View
2018-10-22
Sale
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
4,349 $5 6,641,634
(Indirect)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
437,706 $0 6,641,634
(Indirect)
View
2018-10-22
Conversion
2018-10-24
5:01 pm
N/A
N/A
PhaseBio Pharmaceuticals Inc PHAS NEW ENTERPRISE ASSOCIATES 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
BARRETT M JAMES
BARRIS PETER J
BASKETT FOREST
KERINS PATRICK J
MOTT DAVID M
SANDELL SCOTT D
Viswanathan Ravi
10% Owner
1,124,301 $0 6,641,634
(Indirect)
View
2018-10-10
Conversion
2018-10-10
6:32 pm
N/A
N/A
Elastic N.V. ESTC MOTT DAVID M
10% Owner
4,155,995 $0 4,155,995
(Indirect)
View
2018-10-10
Conversion
2018-10-10
6:32 pm
N/A
N/A
Elastic N.V. ESTC MOTT DAVID M
10% Owner
1,528,117 $0 4,155,995
(Indirect)
View
2018-10-10
Conversion
2018-10-10
6:32 pm
N/A
N/A
Elastic N.V. ESTC MOTT DAVID M
10% Owner
4,155,995 $0 4,155,995
(Indirect)
View
2018-10-10
Conversion
2018-10-10
6:32 pm
N/A
N/A
Elastic N.V. ESTC MOTT DAVID M
10% Owner
1,528,117 $0 4,155,995
(Indirect)
View
2018-09-20
Option Award
2018-09-21
4:50 pm
N/A
2028-09-20
Mersana Therapeutics Inc. MRSN MOTT DAVID M
Director, 10% Owner
10,000 $12.27 10,000
(Direct)
View
2018-07-02
Option Award
2018-07-02
5:37 pm
N/A
N/A
Epizyme Inc. EPZM MOTT DAVID M
Director
6,088 $13.55 6,054,351
(Direct)
View
2018-06-22
Option Award
2018-06-26
5:07 pm
2019-06-22
2028-06-22
Adaptimmune Therapeutics PLC ADAP MOTT DAVID M
Director, 10% Owner
187,330 $2.18 187,330
(Direct)
View
2018-06-13
Option Award
2018-06-15
7:25 pm
N/A
N/A
ARDELYX Inc ARDX MOTT DAVID M
Director, 10% Owner
20,843 $0 3,082,186
(Direct)
View
2018-06-13
Option Award
2018-06-15
7:25 pm
N/A
2028-06-13
ARDELYX Inc ARDX MOTT DAVID M
Director, 10% Owner
15,000 $4.03 3,082,186
(Direct)
View
2018-06-01
Option Award
2018-06-05
5:26 pm
N/A
N/A
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
2,537 $0 9,681,039
(Direct)
View
2018-06-01
Option Award
2018-06-05
5:26 pm
N/A
2028-06-01
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
7,209 $46.89 9,681,039
(Direct)
View
2018-06-01
Option Award
2018-06-05
5:26 pm
N/A
N/A
TESARO Inc. TSRO MOTT DAVID M
Director, 10% Owner
4,052 $0 9,681,039
(Direct)
View
2018-05-18
Option Award
2018-05-31
4:29 pm
N/A
2028-05-17
Epizyme Inc. EPZM MOTT DAVID M
Director
12,500 $17 12,500
(Direct)
View
2018-05-25
Option Award
2018-05-30
5:05 pm
N/A
N/A
ARDELYX Inc ARDX MOTT DAVID M
Director, 10% Owner
416,666 $4 3,082,186
(Indirect)
View
2018-05-25
Option Award
2018-05-30
5:05 pm
N/A
N/A
ARDELYX Inc ARDX MOTT DAVID M
Director, 10% Owner
416,667 $4 3,082,186
(Indirect)
View
Goto page 0, 1, Next